Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SPH3127 (DRI 18) is a potent, orally active, novel direct renin inhibitor with IC50 values of 0.4 nM and 0.45 nM for recombinant human-renin and human plasma renin activity, respectively. SPH3127 has an anti-hypertensive effect and can be used to study hypertension.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,140.00 | |
50 mg | 8-10 weeks | $ 2,785.00 | |
100 mg | 8-10 weeks | $ 3,520.00 |
Description | SPH3127 (DRI 18) is a potent, orally active, novel direct renin inhibitor with IC50 values of 0.4 nM and 0.45 nM for recombinant human-renin and human plasma renin activity, respectively. SPH3127 has an anti-hypertensive effect and can be used to study hypertension. |
Molecular Weight | 444.53 |
Formula | C22H32N6O4 |
CAS No. | 1399849-02-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SPH3127 1399849-02-5 inhibitor inhibit